CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis

Abstract

Microglia and non-professional immune cells (endothelial cells, neurons) participate in the recognition and removal of pathogens and tissue debris in the injured central nervous system through major pro-inflammatory processes. However, the mechanisms involved in regulating these responses remain ill-characterized. We herein show that CD93, also known as complement C1qRp/AA4 stem cell marker, has an important role in the regulation of inflammatory processes. The role of CD93 was evaluated in two models of neuroinflammation. We used the MOG-experimental autoimmune encephalomyelitis (EAE) model and the antibody-dependent EAE (ADEAE), which were induced in wild-type and CD93 knockout mice. We found that CD93 was highly expressed by neurons, endothelial cells and microglia (ramified >> amoeboid). Astrocytes and oligodendrocytes did not to express CD93. We further observed that CD93-deficient (CD93−/−) mice presented a more robust brain and spinal cord inflammation in EAE and ADEAE. Encephalitis in CD93−/− was characterized by increased numbers of infiltrating M1 macrophages (CD11c+ CD206−) and amoeboid microglia exhibiting a more activated phenotype (Tomato Lectinhigh Cox2high). Damage to and leakage through the blood–brain barrier was increased in CD93−/− animals and was associated with a more robust neuronal injury when compared with wild-type EAE mice. We propose that CD93 is an important neuro-immune regulator to control central nervous system inflammation.